According to NeuroMetrix, Quell is a wearable intensive nerve stimulation device that stimulates sensory nerves in the upper calf sending neural pulses to the brain.
Tag: Neuropathy
The U.S. FDA has approved the supplemental New Drug Application (sNDA), submitted by Janssen Pharmaceuticals, for NUCYNTA ER (tapentadol) extended-release tablets. NUCYNTA ER is an oral analgesic taken twice daily, for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
Pfizer Inc. has announced that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline...
Currently, there are no safe and effective drugs on the market for treating gastroparesis...
Diabetic Peripheral Neuropathy (DPN) is nerve damage that affects the feet, legs, arms and hands. It's a potential complication of diabetes, and it's a frightening one which most people know very little about. People experience DPN in a variety of ways. They may feel burning, shooting pain...
Pfizer Inc. announced, at the request of the U.S. Food and Drug Administration (FDA), the suspension of the chronic low back pain and painful diabetic peripheral neuropathy studies in the clinical program for the investigational compound tanezumab. Investigation of the compound continues in some areas of high unmet medical need, including cancer pain...